RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Zosano Pharma Stock

Zosano Pharma ROE 2024

Zosano Pharma ROE

-0.91

Ticker

ZSAN

ISIN

US98979H2022

WKN

A2JSFT

In 2024, Zosano Pharma's return on equity (ROE) was -0.91, a 0% increase from the 0 ROE in the previous year.

Zosano Pharma Aktienanalyse

What does Zosano Pharma do?

Zosano Pharma Corp is a biopharmaceutical company focused on the development and marketing of innovative therapeutics. The company was founded in 2006 and is headquartered in Fremont, California. Business model Zosano Pharma Corp follows a unique business model based on the development of unique drugs using its proprietary ZP Patch technology platform. The technology involves the administration of drugs through a microneedle-based delivery system. This method allows for fast and effective treatment of various diseases and conditions. Business divisions Zosano Pharma Corp is divided into several business divisions, all of which aim to develop and market pharmaceuticals. One of the main divisions is oncology, where the company develops compounds that can be used in the treatment of cancer. In addition, the company is also active in neurology and is working on the development of therapeutic agents for the treatment of brain and nervous system disorders. The focus here is on the treatment of migraines and other types of headaches. Products Zosano Pharma Corp currently offers a range of products based on the ZP Patch technology. One of the main products is Qtrypta, a medication for the treatment of migraines. The medication is administered through the microneedle-based ZP Patch technology, allowing for fast and effective treatment of migraine attacks. Another important product is ZolpiMist, a prescription sleep aid that is also administered through the ZP Patch technology. The medication is fast-acting and effective in treating sleep disorders. In addition to these products, Zosano Pharma Corp is also working on the development of new drugs based on the ZP Patch technology. The focus here is on the development of innovative drugs for the treatment of cancer and other serious diseases. Conclusion Zosano Pharma Corp is an innovative biopharmaceutical company focused on the development and marketing of unique drugs. With the ZP Patch technology, the company has created a unique platform that allows for fast and effective drug administration, offering patients the best possible treatment outcomes. With its products and ongoing development of new medications, Zosano Pharma Corp is a leading company in the biopharmaceutical industry and will continue to play an important role in the treatment of serious diseases. Zosano Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Zosano Pharma's Return on Equity (ROE)

Zosano Pharma's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Zosano Pharma's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Zosano Pharma's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Zosano Pharma’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Zosano Pharma stock

What is the ROE (Return on Equity) of Zosano Pharma this year?

The ROE of Zosano Pharma this year is -0.91 undefined.

How has the Return on Equity (ROE) of Zosano Pharma developed compared to the previous year?

The ROE of Zosano Pharma has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Zosano Pharma?

A high ROE indicates that Zosano Pharma generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Zosano Pharma?

A low ROE can indicate that Zosano Pharma is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Zosano Pharma affect the company?

A change in ROE (Return on Equity) of Zosano Pharma can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Zosano Pharma?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Zosano Pharma?

Some factors that can influence Zosano Pharma's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Zosano Pharma pay?

Over the past 12 months, Zosano Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zosano Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Zosano Pharma?

The current dividend yield of Zosano Pharma is .

When does Zosano Pharma pay dividends?

Zosano Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Zosano Pharma?

Zosano Pharma paid dividends every year for the past 0 years.

What is the dividend of Zosano Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Zosano Pharma located?

Zosano Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Zosano Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zosano Pharma from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Zosano Pharma pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Zosano Pharma in the year 2023?

In the year 2023, Zosano Pharma distributed 0 USD as dividends.

In which currency does Zosano Pharma pay out the dividend?

The dividends of Zosano Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Zosano Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Zosano Pharma

Our stock analysis for Zosano Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zosano Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.